ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,649.21
      1.31%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      04/24/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Issuance of a Patent Covering the use of Ruxolitinib and its Deuterated Forms to Treat Alopeci...NASDAQ:ACRSAclaris Therapeutics Inc
      04/04/20197:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      03/29/20194:41PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRSAclaris Therapeutics Inc
      03/27/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferenceNASDAQ:ACRSAclaris Therapeutics Inc
      03/18/20198:03AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ACRSAclaris Therapeutics Inc
      03/18/20197:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      03/18/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Clinical and Commerci...NASDAQ:ACRSAclaris Therapeutics Inc
      03/08/20194:54PMGlobeNewswire Inc.CORRECTION - Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 18, 2019NASDAQ:ACRSAclaris Therapeutics Inc
      03/08/20194:01PMGlobeNewswire Inc.Aclaris Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 18, 2019NASDAQ:ACRSAclaris Therapeutics Inc
      03/04/20196:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      03/04/20196:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      03/04/20196:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      03/04/20196:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      03/04/20196:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/28/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics Receives European Approvals of ESKATA® (hydrogen peroxide) cutaneous solution, 685 mgNASDAQ:ACRSAclaris Therapeutics Inc
      02/19/20197:00AMGlobeNewswire Inc.Aclaris Therapeutics to Present Scientific Posters at the 77th Annual Meeting of the American Academy of DermatologyNASDAQ:ACRSAclaris Therapeutics Inc
      02/14/20194:26PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/14/20193:37PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/13/201911:47AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/12/20194:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      02/08/20195:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20196:36PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20196:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20196:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20196:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20196:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/05/20196:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      02/04/201910:15AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
      01/29/20194:24PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      01/25/20192:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS